Loading...
Loading...
PEARW| Name | Value |
|---|---|
| Revenues | 4.1M |
| Cost of Revenue | 2.6M |
| Gross Profit | 1.5M |
| Operating Expense | 28.2M |
| Operating I/L | -26.6M |
| Other Income/Expense | -4.1M |
| Interest Income | 0.0M |
| Pretax | -30.7M |
| Income Tax Expense | 4.1M |
| Net Income/Loss | -34.8M |
Pear Therapeutics, Inc. specializes in developing and commercializing software-based medicines for severe psychiatric and neurologic conditions. Their products include PearConnect, a patient service center for prescription digital therapeutics; reSET for substance use disorder treatment; reSET-O for opioid use disorder treatment; and Somryst for chronic insomnia treatment.
